PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : C1-Esterase inhibitor - Hereditary angiodema - EMERGENCY treatment
PAD Profile : C1-Esterase inhibitor - Hereditary angiodema - EMERGENCY treatment Important
Keywords :
acute hereditary angiodema
Brand Names Include :
Berinert, Cetor, Cinryze
Important Information :
Prevention / prophylaxis is commissioned by NHSE. RSFT are the only Surrey Trust to which this applies.
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
03. Respiratory System
03.04.03. Allergic emergencies